Author: Cynthia Robbins-rothPublisher: Perseus Books
ISBN:
Category : Business & Economics
Languages : en
Pages : 280
Book Description
A fascinating glimpse inside the life-and-death business of biotechnology.
From Alchemy to Ipo
Author: Cynthia Robbins-RothPublisher: Westview Publishing
ISBN: 9780738204826
Category : Business & Economics
Languages : en
Pages : 253
Book Description
Analyzing the impact of biotechnology on everyday life and business, this fascinating book by an industry insider paints a vivid portrait of this emerging and powerful branch of science and technology. Reprint. 20,000 first printing.
The Race to Commercialize Biotechnology
Author: Steven CollinsPublisher: Routledge
ISBN: 1134456085
Category : History
Languages : en
Pages : 229
Book Description
This comparative study looks at the early development of biotechnology in the US and Japan. Drawing on primary and secondary sources it traces the historical roots of recombinant DNA technology, discusses the tensions between regulation and promotional policies and identifies the major actors and strategies that launched biotechnology in both countries. Developing several strands of theory in economic history, science and technology policy, the book proposes a simple model that relates the differences in the two countries' responses to variations in the availability of institutional, financial and organizational resources needed to commercialize the new technology.
Biocapital
Author: Kaushik Sunder RajanPublisher: Duke University Press
ISBN: 0822388006
Category : Business & Economics
Languages : en
Pages : 359
Book Description
Biocapital is a major theoretical contribution to science studies and political economy. Grounding his analysis in a multi-sited ethnography of genomic research and drug development marketplaces in the United States and India, Kaushik Sunder Rajan argues that contemporary biotechnologies such as genomics can only be understood in relation to the economic markets within which they emerge. Sunder Rajan conducted fieldwork in biotechnology labs and in small start-up companies in the United States (mostly in the San Francisco Bay area) and India (mainly in New Delhi, Hyderabad, and Bombay) over a five-year period spanning 1999 to 2004. He draws on his research with scientists, entrepreneurs, venture capitalists, and policymakers to compare drug development in the two countries, examining the practices and goals of research, the financing mechanisms, the relevant government regulations, and the hype and marketing surrounding promising new technologies. In the process, he illuminates the global flow of ideas, information, capital, and people connected to biotech initiatives. Sunder Rajan’s ethnography informs his theoretically sophisticated inquiry into how the contemporary world is shaped by the marriage of biotechnology and market forces, by what he calls technoscientific capitalism. Bringing Marxian theories of value into conversation with Foucaultian notions of biopolitics, he traces how the life sciences came to be significant producers of both economic and epistemic value in the late twentieth century and early twenty-first.
Science, the State and the City
Author: Geoffrey OwenPublisher: Oxford University Press
ISBN: 019872800X
Category : Business & Economics
Languages : en
Pages : 266
Book Description
The book is about the link between science and business - how discoveries made in academic laboratories are taken up by venture capitalists and investors, and converted into products which, if they are successful, provide treatments for disease and may generate substantial returns for investors.
Biotech Industry
Author: Bryan BergeronPublisher: John Wiley & Sons
ISBN: 0471647578
Category : Business & Economics
Languages : en
Pages : 384
Book Description
"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc. "Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures. An in-depth examination of the growth and financing of the biotechnology industry worldwide Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing. Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.
Translational Multimodality Optical Imaging
Author: Fred S. AzarPublisher: Artech House
ISBN: 1596933089
Category : Medical
Languages : en
Pages : 431
Book Description
Supported with 119 illustrations, this milestone work discusses key optical imaging techniques in self-contained chapters; describes the integration of optical imaging techniques with other modalities like MRI, X-ray imaging, and PET imaging; provides a software platform for multimodal integration; presents cutting-edge computational and data processing techniques that ensure rapid, cost-effective, and precise quantification and characterization of the clinical data; covers advances in photodynamic therapy and molecular imaging, and reviews key clinical studies in optical imaging along with regulatory and business issues.
Clusters, Networks and Innovation
Author: Stefano BreschiPublisher: Oxford University Press
ISBN: 0199275556
Category : Business & Economics
Languages : en
Pages : 524
Book Description
Examining the role of the much-vaunted concepts of regional clusters in the prosperity and economic expansion of countries, this work looks at the different experiences of industrial districts and high-tech regions such as Silicon Valley, Boston's biotech region, and Hsinchu-Taipei.
The Recombinant University
Author: Doogab YiPublisher: University of Chicago Press
ISBN: 022614383X
Category : Education
Languages : en
Pages : 331
Book Description
This title examines the history of biotechnology when it was new, especially when synonymous with recombinant DNA technology. It focuses on the academic community in the San Francisco Bay Area where recombinant DNA technology was developed and adopted as the first major commercial technology for genetic engineering at Stanford in the 1970s. The book argues that biotechnology was initially a hybrid creation of academic and commercial institutions held together by the assumption of a positive relationship between private ownership and the public interest.
Resistance Is Fertile
Author: Wilhelm PeekhausPublisher: UBC Press
ISBN: 0774823127
Category : Science
Languages : en
Pages : 313
Book Description
For decades, government, industry, and the mainstream media have extolled the virtues of biotechnology while downplaying its negative side effects. Focusing on agriculture, Resistance Is Fertile challenges this dominant rhetoric by analyzing the major issues around which opponents of biotechnology in Canada are mobilizing resistance – namely, the enclosure of the biological and the knowledge commons, which together form the BioCommons. What emerges is an empirically and theoretically informed analysis of Canada’s regulatory regime, the corporate control of seeds, and attempts to construct and control public discussions about agricultural biotechnology.
